Cimarron E. Sharon

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma

Cimarron E. Sharon, G.N. Tortorello, A.C. Huang et al. · Annals of Oncology · 2023 · 32 citations · Full text

Surgical Oncology, Medicine, Melanoma +9

The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex

Andrew J. Sinnamon, Cimarron E. Sharon, Yun Song et al. · Journal of the American Academy of Dermatology · 2018 · 30 citations

Skin Cancer, Primary Melanoma Varies, Medicine +9

Association of Marital Status With T Stage at Presentation and Management of Early-Stage Melanoma

Cimarron E. Sharon, Andrew J. Sinnamon, Michael E. Ming et al. · JAMA Dermatology · 2018 · 29 citations · Full text

Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study

Adrienne B. Shannon, Cimarron E. Sharon, Richard J. Straker et al. · Journal of the American Academy of Dermatology · 2022 · 24 citations

Dermoscopic Image, Surgical Oncology, Medicine +8

Sentinel lymph node biopsy status improves adjuvant therapy decision-making in patients with clinical stage IIB/C melanoma: A population-based analysis

Cimarron E. Sharon, Richard J. Straker, Phyllis A. Gimotty et al. · Journal of the American Academy of Dermatology · 2022 · 22 citations · Full text

Surgical Oncology, Adjuvant Therapy Decision-making, Skin Cancer +10